Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 720-725

  Chu, Te Hua Tearina ^a,c   Dornburg, Ralph ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHIMERIC PROTEIN; GAG PROTEIN; GENE PRODUCT; HYBRID PROTEIN; MONOCLONAL ANTIBODY; POL PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; CELL LINE; COLONY FORMING UNIT; CONTROLLED STUDY; GENE TARGETING; GENE TRANSFER; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PLASMID; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; VIRUS PARTICLE; VIRUS TITRATION;

EID: 0031060146     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.720-725.1997     Document Type: Article

References (27)

1. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J.-K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
2. Chu, T.-H. T., and R. Dornhurg. 1995. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J. Virol. 69:2659-2663.
3. Chu, T.-H. T., I. Martinez, P. Olson, and R. Dornhurg. 1945. Highly efficient eucaryotic gene expression vectors for peptide secretion. BioTechniques 18:890-899.
4. Chu, T.-H. T., I. Martinez, W. C. Sheay, and R. Dornburg. 1994. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Ther. 1:292-299.
5. Cournoyer, D., and C. T. Caskey. 1993. Gene therapy of the immune system. Annu. Rev. Immunol. 11:297-329.
6. Cui, Z.-Z., L. F. Lee, R. F. Silvia, and R. L. Witter. 1986. Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes. J. Immunol. 136:4237-4242.
7. Dornburg, R. 1995. Reticuloendotheliosis viruses and derived vectors. Gene Ther. 2:301-310.
8. Dropubic, B., and K.-T. Jeang. 1994. Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention. Hum. Gene Ther. 5:927-939.
9. Etienne-Julan, M., P. Roux, S. Carillo, P. Jeanteur, and M. Piechaczyk. 1992. The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker. J. Gen. Virol. 73:3251-3255.
10. Gilmore, T. D., and H. M. Temin. 1986. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell 44:791-800.
11. Hunter, E., and R. Swanstrom. 1990. Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157:187-253.
12. Kasahara, N., A. M. Dozy, and Y. W. Kan. 1994. Tissue-specific targeting of retroviral vectors through ligand-receplor interactions. Science 266:1373-1376.
13. Kawai, S., and M. Nishizawa. 1984. New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol. Cell. Biol. 4:1172-1174.
14. Malhotra, S., A. G. Scott, T. Zavorotinskaya, and L. M. Albritton. 1996. Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry. J. Virol. 70:321-326.
15. 14a.Martinez, I., and R. Dornburg. Unpublished data.
16. Martinez, I., and R. Dornburg. 1995. Mapping of receptor binding domains in the envelope protein of spleen necrosis virus. J. Virol. 69:4339-4346.
17. Martinez, I., and R. Dornburg. 1995. Improved retroviral packaging lines derived from spleen necrosis virus. Virology 208:234-241.
18. Martinez, I., and R. Dornburg. 1996. Partial reconstitution of a replication-competent retrovirus in helper cells with partial overlaps between vector and helper cell genomes. Hum. Gene Ther. 7:705-712.
19. Martinez, I., and R. Dornburg. 1996. Mutational analysis of the envelope protein of spleen necrosis virus. J. Virol. 70:6036-6043.
20. Mikawa, T., D. A. Fischman, J. P. Dougherty, and A. M. C. Brown. 1992. In vivo analysis of a new lacZ retrovirus vector suitable for lineage marking in avian and other species. Exp. Cell Res. 195:516-523.
21. Morgan, R. A., and W. F. Anderson. 1993. Human gene therapy. Annu. Rev. Biochem. 62:191-217.
22. Roux, P., P. Jeanteur, and M. Piechaczyk. 1989. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human by means of major histocompalibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses. Proc. Natl. Acad. Sci. USA 86:9079-9083.
23. Russell, S. J., R. E. Hawkins, and G. Winter. 1993. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res. 21:1081-1085.
24. Sheay, W., S. Nelson, I. Martinez, T.-H. T. Chu, and R. Dornburg. 1993. Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eucaryotic vectors. BioTechniques 15:856-861.
25. Somia, N. V., M. Zoppe, and I. M. Verma. 1995. Generation of targeted retroviral vectors by using single-ehain variable fragment: an approach to in vivo gene delivery. Proc. Natl. Acad. Sci. USA 92:7570-7574.
26. Young, J. A. T., P. Bates, K. Willert, and H. E. Varmus. 1990. Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science 250:1421-1423.
27. Yu, M., E. Poeschla, and F. Wong-Staal. 1994. Progress towards gene therapy for HIV infection. Gene Ther. 1:13-26.